Global Brain and Nervous System Disorders Research Across the Lifespan (R21)
The summary for the Global Brain and Nervous System Disorders Research Across the Lifespan (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Global Brain and Nervous System Disorders Research Across the Lifespan (R21): This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, proposing the development of innovative, collaborative research projects on brain and other nervous system function and disorders throughout life, relevant to low- and middle-income countries (LMICs). Scientists in the United States (U.S.) or upper middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions. Income categories used are as defined by the World Bank at http://data.worldbank.org/about/country-classifications/country-and-lending-groups. These grants are expected to inform the development of more comprehensive research programs that contribute to the long-term goals of building sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, prevention, treatment and implementation strategies. The proposed work may also contribute to developing a base for research networking and evidence-based policy beyond the specific research project.
Federal Grant Title: | Global Brain and Nervous System Disorders Research Across the Lifespan (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Environment Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-14-331 |
Type of Funding: | Grant |
CFDA Numbers: | 93.113, 93.173, 93.242, 93.279, 93.853, 93.865, 93.866, 93.989 |
CFDA Descriptions: | Environmental Health; Research Related to Deafness and Communication Disorders; Mental Health Research Grants; Drug Abuse and Addiction Research Programs; Extramural Research Programs in the Neurosciences and Neurological Disorders; Child Health and Human Development Extramural Research; Aging Research; International Research and Research Training |
Current Application Deadline: | Jan 5, 2017 |
Original Application Deadline: | Jan 5, 2017 |
Posted Date: | September 5th, 2014 |
Creation Date: | Sep 5, 2014 |
Archive Date: | Feb 5, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | $125,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Private institutions of higher education
Public and State controlled institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
To determine country income categories, please view the following: http://data.worldbank.org/country. The subcategories of LMICs are: upper-middle-income (UMIC), lower-middle-income and low-income countries.
At least one institution in the U.S. or an UMIC, and at least one institution in a LMIC must be involved as partners in the grant application (UMIC institutions are eligible to partner either with U.S. institutions or directly with other LMIC institutions with no U.S. partner).
Exceptions:
Foreign high income country (HIC) institutions are not eligible institutional partners under this FOA.
Note that Hong Kong-based institutions are not eligible as applicant or primary LMIC partner institutions. As long as China remains a LMIC, a second institution in mainland China must be involved as the primary collaborating UMIC institution if an institution in Hong Kong is included.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-14-331.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed...
- • NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advan...
- • Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clini...
- • Outstanding New Environmental Scientist Award (ONES)
- • Environmental Health Sciences Core Center Grants
- • Leiomyomata Uteri: Basic Science and Translational Research
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)